Edwards Lifesciences CEO Bernard J. Zovighian sold 523 shares of common stock at $87.92 per share. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan.
Edwards Lifesciences CEO Sells Shares Under 10b5-1 Plan
Edwards LifesciencesInsider Sale10b5-1 PlanExecutive TransactionsHealthcare


